PetCaseFinder

Peer-reviewed veterinary case report

Does the Assisi Anti-anxiety Device Help Dogs with Separation Anxiety

By Pankratz, Katherine et al.·Published in Frontiers in veterinary science·2021·Department of Clinical Sciences, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Randomized, Placebo-Controlled Prospective Clinical Trial Evaluating the Efficacy of the Assisi Anti-anxiety Device (Calmer Canine) for the Treatment of Canine Separation Anxiety.

Species:
dog
Behaviour & energyDogs

Plain-English summary

A group of dogs with moderate to severe separation anxiety (SA) was treated with a pulsed electromagnetic field (PEMF) device designed to help reduce their anxiety when left alone. Owners used the device twice daily for six weeks and reported their dogs' behaviors through questionnaires and videos. By the end of the study, dogs using the PEMF device showed a significant decrease in negative behaviors compared to those using a placebo device. The treatment was found to be safe, with any reported side effects resolving quickly. Overall, the PEMF device appears to be an effective option for managing canine separation anxiety.

People also search for: dog separation anxiety treatment · PEMF device for dogs · how to help my dog with anxiety

Abstract

Separation anxiety (SA) is among the most common canine behavior disorders and affects quality-of-life for dogs and their owners. Dogs with SA show signs of anxiety during absence or perceived absence of their owners. While psychoactive medications are often helpful for treating SA, dog and human factors may limit their utility. This study explored the efficacy of a pulsed electromagnetic field (PEMF) device for treatment of canine SA.In this double-blind randomized placebo-controlled study, a screening questionnaire and baseline video confirmed the diagnosis of SA. Owners treated their dog with the device twice daily for 6 weeks, completed weekly questionnaires, and noted adverse events. Videos were taken of the dog while alone at weeks 4 and 6. Behaviors were coded and categorized as negative and positive. Questionnaire and video data at weeks 4 and 6 were compared to baseline.Forty client-owned dogs with moderate to severe SA completed the study. There were no differences between groups for age, weight, or sex. In owner questionnaires, no difference in behavior or overall score was found between the active and sham groups (> 0.05). Videos of the active group compared to the sham group showed significant reduction in negative behaviors by week 6 (= 0.036) and higher percentage of success at week 4 (= 2.83,= 0.005), at week 6 (= 1.65,= 0.098), and across the full study (= 1.99,= 0.047). Adverse events were reported in eight dogs (6 active, 2 sham); all resolved and were unlikely to be related to treatment.This study supports the efficacy and safety of this PEMF device for treatment of SA in dogs. Questionnaire results may not be sensitive enough to detect subtle negative behavioral states compared to video, and may not capture other owner observed behavioral changes. A caregiver placebo effect may account for some improvement seen in both groups. Video data appear better for diagnosis and monitoring dog's behavior when left alone. Future studies should assess PEMF's impact on other anxieties or combination of anxiety disorders in dogs.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/34988140/